Skip to main navigation
  • About SIGA
  • Products
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Contact Audit Committee
    • Stock Information
    • Investor FAQs
    • Investor Contact
  • News
  • Careers
  • Contact

SIGA: Human BioArmor

Providing solutions for unmet needs in health security
  • About SIGA
  • Products
  • Investors
  • News
  • Careers
  • Contact

Financial Information

Investors
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
    • Contact Audit Committee
  • Stock Information
  • Investor FAQs
  • Investor Contact

Financial Information

Here you will find a summary of SIGA's latest financial information.

Latest 10-Qs

Filing date View
Nov 03, 2022 View HTML
0001437749-22-025799.pdf
0001437749-22-025799.rtf
0001437749-22-025799.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 04, 2022 View HTML
0001437749-22-018940.pdf
0001437749-22-018940.rtf
0001437749-22-018940.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Latest 10-K

Filing date View
Mar 03, 2022 View HTML
0001437749-22-005179.pdf
0001437749-22-005179.rtf
0001437749-22-005179.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Latest Proxy Statement

Filing date View
Apr 27, 2022 View HTML
0001140361-22-016274.pdf
0001140361-22-016274.rtf
0001140361-22-016274.xls

Related Links

  • About SIGA
  • Products
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Contact Audit Committee
    • Stock Information
    • Investor FAQs
    • Investor Contact
  • News
  • Careers
  • Contact

Shareholder Tools

Print
Email Alerts
RSS News Feeds
Contact IR

SIGA: Human BioArmor

  • Corporate Headquarters
    31 East 62nd Street
    New York, NY 10065
    (212) 672-9100

  • SIGA Development Operations
    4575 SW Research Way, Suite 110
    Corvallis, OR 97333
    (541) 753-2000

  • Privacy Notice

© SIGA Technologies, All Rights Reserved